Back
US Physical Therapy Vs. Novartis AG Industry Stock Comparison
Sell
46
USPH
US Physical Therapy
Last Price:
$73.24
Seasonality Move:
11.7%
Buy
71
NVSEF
Novartis AG
Last Price:
$116.60
Seasonality Move:
6.56%
Sell
46
US Physical Therapy (USPH)
is a Sell
Is US Physical Therapy a Buy, Sell or Hold?
-
The current US Physical Therapy [USPH] share price is $73.65. The Score for USPH is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
USPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $116.60. The Score for NVSEF is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
USPH Stock Price Chart
What is US Physical Therapy's stock price today?
-
The US Physical Therapy share price today is $73.65Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and USPH is experiencing slight selling pressure.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $116.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVSEF is experiencing slight buying pressure.
USPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.32 | Sell |
Relative Strength Index (14 RSI): | 27.65 | Sell |
Chaikin Money Flow: | -32559 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (76.08 - 85.82) | Sell |
Bollinger Bands (100): | (81.79 - 94.67) | Sell |
NVSEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.84 | Buy |
Relative Strength Index (14 RSI): | 61.26 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (107.1 - 113.78) | Buy |
Bollinger Bands (100): | (98.55 - 109.41) | Buy |
USPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 75.41 | Sell |
20-day SMA: | 79.39 | Sell |
50-day SMA: | 84.8 | Sell |
200-day SMA: | 88.59 | Sell |
8-day EMA: | 75.48 | Sell |
20-day EMA: | 78.77 | Sell |
50-day EMA: | 83.24 | Sell |
200-day EMA: | 88.91 | Sell |
NVSEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 110.96 | Buy |
20-day SMA: | 111.23 | Buy |
50-day SMA: | 106.01 | Buy |
200-day SMA: | 106.77 | Buy |
8-day EMA: | 112.31 | Buy |
20-day EMA: | 110.66 | Buy |
50-day EMA: | 107.55 | Buy |
200-day EMA: | 104.74 | Buy |
US Physical Therapy Earnings Growth & USPH Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.23 per share, an increase this year of $0.01 per share, and an increase next year of $0.28 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
US Physical Therapy Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novartis AG Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |